The product portfolio for different procedures and treatments is the result of a conscientious innovation strategy and R&D investment
ABIMO (the Brazilian Medical Devices Manufacturers Association) studies have shown that innovation is considered essential by the Brazilian industry in the sector. At least 80% of companies have their own R&D departments and more than 2/3 (68%) have a strategic innovation plan.
“In the current global trade scenario of competition and dynamism, investing in innovation is a necessity and Brazil’s health products and equipment industry already knows it, as evidenced by our research”, says Clara Porto, the ABIMO marketing and exports manager. “Recognising this reality, ABIMO created the Health Innovation Prize back in 2010, to honour the most innovative solutions offered by the Brazilian industry”, she adds.
Below is some of the innovation Brazilian stands will be showing at MEDICA, in Dusseldorf:
Magnamed creates lung ventilator and anaesthesia solutions, exporting two of its machines – the OxyMag is a portable ventilator, while the FlexiMag Plus is an ICU ventilator – to more than 40 countries. The innovation in the OxyMag is that it has an intuitive, user friendly interface that makes it easier and faster to take action in emergencies. The company won the Innovating Health Prize in 2013.
Timpel won the Innovating Health Prize in 2015 for its Timpel Enlight 1800, a bedside lung monitor for use in hospital environments (ICU, Surgery Centre, Accident and Emergency and Walk-in Clinics). The device provides real-time imaging of lung ventilation/perfusion distribution, making it possible to identify collapses and alveolar hyperdistention, filling assynchronisms, pneumothorax, selective intubation and lung perfusion alterations, among others.
The equipment carries out ultra-fast image capture (50 per second), issues no radiation and does not require the use of contrasts. It offers the patient more safety, physicians can use it to diagnose the lung condition more quickly, it optimises ventilation (supports the decision) and allows for fast haemodynamic checks (while being non-invasive).
Duan International developed the Venoscópio, a creative and inexpensive solution. This tool uses LED lights that shine onto the skin, permeating the subcutaneous tissue by up to 5 mm, and highlights veins, allowing the health professional to identify the three main parameters for a good venepuncture: real vein calibre/diameter, pathways/branching, and existing permeability/obstructions. The image of the vein is direct, not reflected, which reduces the risk of error.
Another advantage the Venoscópio offers is that it allows visualisation of whether the medication is kept to the lumen of the vein and to identify haematomas in accidents, as a perforation of veins. The Venoscópio dispenses the use of garrottes and tourniquets. Furthermore, it improves the blood collection by being faster than the traditional procedure, also reducing the risk of biochemical and haematological alterations in the sample.
Ibramed, a manufacturer of rehabilitation and aesthetic medicine equipment, developed a product especially for the Rio 2016 Olympics – the Neurodyn Aussie Sport. This product accelerates athletes’ recovery process after an injury through the use of the Corrente Aussie to for sensory and motor stimulation. It is mainly indicated for muscular strengthening, motor re-education, reducing oedemas and modulating pain, among others.
FOR THE HEART
Corcam innovated with the Nexcor, a system that brings current hospital technology to users, getting cardiac patients close to their physicians. The monitor can identify infarction in its initial phase and rare arrhythmia syndromes using software that sends real-time patient data to a centre that passes on the information to the respective physicians.
Developed over the course of five years of research, the new heart monitor can detect falls, has a GPS to locate patients who have lost consciousness and a panic button to call for help with one touch, in addition to sending alerts in the event of infarction or arrhythmia.
Scitech was the first company in South America to develop a pharmacological stent, an implantable product for the treatment of coronary diseases. The company was also a pioneer in the region, in developing a non-pharmacological coronary stent and accessories for interventionist cardiology.
BRAZILIAN HEALTH DEVICES AT MEDICA 2016: Hall 17 (ABIMO 17 A38 ), Hall 3 (stands 3 B64) and Hall 4 (stands 4 J06)
ABOUT BRAZILIAN HEALTH DEVICES
The mission of the Brazilian Health Devices project, run by ABIMO in partnership with Apex-Brasil, is to nurture the industry’s exports of health articles and equipment. BHD is the brand that unites the national sector’s exporters and represents them internationally.
ABIMO (the Brazilian Medical Devices Manufacturers Association) is the agency that represents the Brazilian health products industry and seeks to promote the sector’s sustainable growth on the national and international stage.
Apex-Brasil (the Brazilian Trade and Investment Promotion Agency) aims to develop the competitive edge of Brazil’s companies by promoting the internationalisation of their business and attracting direct foreign investment. Apex-Brasil currently supports more than 12,000 companies from 80 sectors of the Brazilian economy, which account for exports to more than 200 markets. The agency also coordinates efforts to attract DFI (Direct Foreign Investment) into the country.
For further information, in English, German, Spanish or Portuguese:
AJA Media Solutions
Marcio Damasceno (Berlín) – email@example.com - +49 179 8759154
Maria Luiza Abbott (London) – firstname.lastname@example.org - +44 772 0297199